Leadartis presenting at the AseBio Investor Day 2020

17-09-2020

Leadartis will be presenting its business proposal at the AseBio Investor Day (https://asebioevents.com/investorday/presenting-companies/) to be held on September 28-October 1st. AseBio Investor Day is the leading event allowing Spanish innovative biotechnology projects to be presented to an audience of leading international investors and pharmaceutical & industrial companies. The event is organized by AseBio, the Spanish Bioindustry Association.

Latest News

Leadartis announces the publication "An Fc-free EGFR-specific 4-1BB-agonistic trimerbody displays broad anti-tumor activity in humanized murine cancer models without toxicity” in Clinical Cancer Research
02-04-2021
Leadartis reaches a major milestone with the demonstration of absence of toxicity of its drug candidate in preclinical models
13-01-2021

Leadartis reaches a major milestone with the demonstration of...

Leadartis featured in EXPANSION as a ‘Start up’ that leads the fight against cancer
10-11-2020

...